{"id":"W4389246839","doi":"10.1182/blood-2023-190015","title":"Patient-Reported Outcomes: Danicopan As Add-on Therapy to Ravulizumab or Eculizumab Versus Placebo in Patients with Paroxysmal Nocturnal Hemoglobinuria and Clinically Significant Extravascular Hemolysis","year":2023,"lang":"en","type":"article","venue":"Blood","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Eculizumab; Internal medicine; Placebo; Anemia; Clinical trial; Hemolysis; Gastroenterology; Pediatrics; Surgery; Immunology; Complement system; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002172283,0.0006324367,0.001401689,0.000455097,0.0001829567,0.0006238406,0.0004746821,0.0005251604,0.002063283],"category_scores_gemma":[0.001938168,0.0001736272,0.002214262,0.0004383021,0.0003220374,0.0005096236,0.0003937672,0.001033738,0.0001378701],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005056705,"about_ca_system_score_gemma":0.0005509442,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007123224,"about_ca_topic_score_gemma":0.001285595,"domain_scores_codex":[0.9988999,0.0006084136,0.0001022738,0.0001688827,0.0001095043,0.0001108762],"domain_scores_gemma":[0.9985701,0.000402612,0.0006215373,0.00004925031,0.00008018471,0.0002762646],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8424804,0.004579883,0.07668997,0.002748255,0.01054327,0.00014286,0.0001159039,0.001617101,0.002288181,0.0002115528,0.001694668,0.05688786],"study_design_scores_gemma":[0.2378583,0.2533879,0.4750125,0.0006417886,0.02034332,0.0005374422,0.0003199189,0.005113253,0.002334915,0.0006353459,0.003698167,0.0001171007],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9901544,0.006391356,0.0001612599,0.0002130427,0.00009697193,0.0003112628,0.001263445,0.00001572909,0.001392434],"genre_scores_gemma":[0.9970512,0.0009400518,0.0002415169,0.0002045632,0.0001059895,0.0003322036,0.0008437571,0.000002043351,0.0002785511],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002172283,"threshold_uncertainty_score":0.01148826,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02236022581142936,"score_gpt":0.2780826313466097,"score_spread":0.2557224055351803,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}